$300.88
+0.63 (+0.21%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Price Target
Analyst Price Target
-71.2% upside
Low Target
$54.31
Average Target
$86.77
High Target
$114.95
Current Price
$300.88
Current
$300.88
$300.88
Target
$86.77
$86.77
$54.31
$86.77 avg
$114.95
Scenario Analysis
Bear Case
$54.31
-81.9%
Low target
Base Case
$86.77
-71.2%
Avg target
Bull Case
$114.95
+-61.8%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$382.54
-21.3% from high
52-Week Low
$192.52
+56.3% from low
50-Day SMA
$332.49
-9.5% vs SMA
200-Day SMA
$309.01
-2.6% vs SMA
RSI (14)
40.5
Neutral
Target vs 52W High
$86.77
-77.3% vs high
Next Earnings Report
Nov 9, 2026 · Before Market Open
1d
tomorrow
EPS Est: $1.81
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |